Revenue ₹175 Cr (+62% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Senores Pharmaceuticals LtdSenores Pharmaceuticals delivered a stellar Q4 FY26, with consolidated revenue of 190 crores (up 66% YoY) and EBITDA...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.